Disciplined Investments, LLC Exelixis, Inc. Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$18.17 - $20.48 $236 - $266	13 Added 41.94%	44 $0
Q1 2023 May 10, 2023	SELL	$16.3 - $19.41 $195 - $232	-12 Reduced 27.91%	31 $0
Q4 2022 Feb 01, 2023	BUY	$14.96 - $17.39 $194 - $226	13 Added 43.33%	43 $0
Q3 2022 Nov 03, 2022	SELL	$15.68 - $22.27 $250 - $356	-16 Reduced 34.78%	30 $0
Q2 2022 Aug 09, 2022	BUY	$17.44 - $23.16 $69 - $92	4 Added 9.52%	46 $1,000
Q1 2022 Apr 22, 2022	BUY	$17.03 - $22.67 $715 - $952	42 New	42 $1,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.